Voltage-gated sodium channels link three major parts of epilepsy history: neuronal action potentials, the mechanism of several antiseizure medicines and the discovery of genetic channelopathies.
Why sodium channels matter
Voltage-gated sodium channels generate the rapid inward current that initiates and propagates action potentials.
Controlling repetitive firing therefore became an important antiseizure strategy.
Phenytoin points toward use-dependent block
Phenytoin was discovered through systematic antiseizure screening before its molecular target was known.
Later electrophysiology showed that phenytoin and related medicines preferentially reduce sustained high-frequency firing by stabilising inactivated sodium channels.
Carbamazepine and later sodium-channel medicines
Carbamazepine, lamotrigine and several later antiseizure medicines also affect voltage-gated sodium-channel function, though individual mechanisms differ.
This created one of the largest mechanistic families of antiseizure drugs.
Genetics changes the meaning of a sodium channel
Mutations in sodium-channel genes such as SCN1A demonstrated that ion-channel dysfunction could itself cause epilepsy syndromes.
This connected molecular genetics directly with neuronal excitability.
The same target can require opposite therapeutic thinking
Loss-of-function and gain-of-function variants can have very different consequences depending on the gene and cell type.
For example, some sodium-channel blockers can worsen seizures in particular SCN1A-related disorders, illustrating why mechanism alone is not enough without disease context.
Precision medicine begins to emerge
Genotype–phenotype knowledge is increasingly used to guide therapy in selected channelopathies.
Sodium channels therefore sit at the intersection of classic pharmacology and modern precision epilepsy care.
Related reading
Sources and further reading
- Sodium channels, inherited epilepsy, and antiepileptic drugs
- Voltage-gated sodium channels in epilepsy
Evidence checked: September 2026.